Spexis AG – SIX:SPEX.SW

Spexis AG stock price today

CHF 0.072

Spexis AG key metrics

Market Cap
 3.85M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Spexis AG stock price history

Spexis AG stock forecast

Spexis AG financial statements

Spexis AG alternative data

Spexis AG
Employees

Spexis AG (SIX:SPEX.SW): Employee count
Dec 2024 50

Spexis AG other data

Frequently Asked Questions (FAQ)

  • What's the price of Spexis AG stock today?

    One share of Spexis AG stock can currently be purchased for approximately $0.07.

  • When is Spexis AG's next earnings date?

    Unfortunately, Spexis AG's (SPEX.SW) next earnings date is currently unknown.

  • Does Spexis AG pay dividends?

    No, Spexis AG does not pay dividends.

  • How much money does Spexis AG make?

    Spexis AG has a market capitalization of 3.85M.

  • What is Spexis AG's stock symbol?

    Spexis AG is traded on the SIX under the ticker symbol "SPEX.SW".

  • What is Spexis AG's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Spexis AG?

    Shares of Spexis AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Spexis AG have?

    As Dec 2024, Spexis AG employs 50 workers.

  • When Spexis AG went public?

    Spexis AG is publicly traded company for more then 7 years since IPO on 15 May 2018.

  • What is Spexis AG's official website?

    The official website for Spexis AG is spexisbio.com.

  • How can i contact Spexis AG?

    Spexis AG can be reached via phone at +41 61 567 16 00.

Spexis AG company profile:

Spexis AG

spexisbio.com
Exchange:

SIX

Full time employees:

50

Industry:

Biotechnology

Sector:

Healthcare

Spexis AG, a clinical-stage biopharmaceutical company, engages in discovering, developing, in-licensing, and acquiring molecules for rare diseases and cancer. Its products pipeline includes ColiFin, an inhaled colistimethate sodium product that is in the phase 3 trial for the treatment of cystic fibrosis (CF) infections; Inhaled Murepavadin, a novel class inhaled antibiotic which is in the phase 1 development stage to treat Pseudomonas aeruginosa infection in people with CF; EBX-002 for non-tuberculous mycobacterial lung infections; Balixafortide for oncology and non-oncology indications; New CXCR4 for treating orphan and hematological malignancies, and non-oncology indications; and Outer Membrane Protein Targeting Antibiotic BamA and lipopolysaccharide transport protein A programs. Spexis AG is headquartered in Allschwil, Switzerland.

+41 61 567 16 00
Hegenheimermattweg 125
Allschwil, 4123

:
:
: